Stop TB Partnership

Manufacturers of anti-TB drugs invited to submit expressions of interest

26 July 2011 - Geneva - The Stop TB Partnership's Global Drug Facility (GDF) and the Global Fund invite manufacturers of first, second and third line anti-tuberculosis (TB) drugs to submit expressions of interest for product evaluation by an expert review panel.

Manufacturers should submit dossiers for products not WHO-Prequalified and/or SRA-authorized. The deadline for drug product dossier submissions is 15 September 2011.

Read more [.PDF]